{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:58:19Z","timestamp":1792601899483,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T00:00:00Z","timestamp":1238112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00125-009-1321-z","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T18:12:05Z","timestamp":1238091125000},"page":"1003-1012","source":"Crossref","is-referenced-by-count":236,"title":["The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality"],"prefix":"10.1007","volume":"52","author":[{"given":"S. E.","family":"Kahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zraika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Utzschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,27]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595\u20131607","journal-title":"Diabetes"},{"key":"1321_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3\u201319","journal-title":"Diabetologia"},{"key":"1321_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","volume":"5","author":"E Opie","year":"1901","unstructured":"Opie E (1901) The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islets of Langerhans. J Exp Med 5:527\u2013540","journal-title":"J Exp Med"},{"key":"1321_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/diab.4.5.367","volume":"4","author":"N Maclean","year":"1955","unstructured":"Maclean N, Ogilvie RF (1955) Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4:367\u2013376","journal-title":"Diabetes"},{"key":"1321_CR5","first-page":"110","volume":"4","author":"G Kloppel","year":"1985","unstructured":"Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110\u2013125","journal-title":"Surv Synth Pathol Res"},{"key":"1321_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) \u00df-cell deficit and increased \u00df-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102\u2013110","journal-title":"Diabetes"},{"key":"1321_CR7","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151\u2013159","journal-title":"Diabetes Res"},{"key":"1321_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00251826","volume":"24","author":"J Rahier","year":"1983","unstructured":"Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366\u2013371","journal-title":"Diabetologia"},{"key":"1321_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1620\/tjem.129.273","volume":"129","author":"K Saito","year":"1979","unstructured":"Saito K, Yaginuma N, Takahashi T (1979) Differential volumetry of A, B, and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 129:273\u2013283","journal-title":"Tohoku J Exp Med"},{"key":"1321_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","volume":"45","author":"H Sakuraba","year":"2002","unstructured":"Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S (2002) Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45:85\u201396","journal-title":"Diabetologia"},{"key":"1321_CR11","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2002-020735","volume":"88","author":"KH Yoon","year":"2003","unstructured":"Yoon KH, Ko SH, Cho JH et al (2003) Selective \u00df-cell loss and \u03b1-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300\u20132308","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"1321_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","volume":"10","author":"J Rahier","year":"2008","unstructured":"Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic \u00df-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32\u201342","journal-title":"Diabetes Obes Metab"},{"key":"1321_CR13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1172\/JCI115779","volume":"89","author":"ER Seaquist","year":"1992","unstructured":"Seaquist ER, Robertson RP (1992) Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 89:1761\u20131766","journal-title":"J Clin Invest"},{"key":"1321_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00125-008-1219-1","volume":"52","author":"BA Menge","year":"2009","unstructured":"Menge BA, Schrader H, Breuer TG et al (2009) Metabolic consequences of a 50% partial pancreatectomy in humans. Diabetologia 52:306\u2013317","journal-title":"Diabetologia"},{"key":"1321_CR15","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI110910","volume":"71","author":"S Bonner-Weir","year":"1983","unstructured":"Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71:1544\u20131553","journal-title":"J Clin Invest"},{"key":"1321_CR16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/diab.37.5.600","volume":"37","author":"T Imamura","year":"1988","unstructured":"Imamura T, Koffler M, Helderman JH et al (1988) Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes 37:600\u2013609","journal-title":"Diabetes"},{"key":"1321_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/diab.37.6.723","volume":"37","author":"WK Ward","year":"1988","unstructured":"Ward WK, Wallum BJ, Beard JC, Taborsky GJ Jr, Porte D Jr (1988) Reduction of glycemic potentiation: a sensitive indicator of \u00df-cell loss in partially pancreatectomized dogs. Diabetes 37:723\u2013729","journal-title":"Diabetes"},{"key":"1321_CR18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jcem-67-4-785","volume":"67","author":"DK McCulloch","year":"1988","unstructured":"McCulloch DK, Raghu PK, Johnston C et al (1988) Defects in \u00df-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes. J Clin Endocrinol Metab 67:785\u2013792","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00452067","volume":"29","author":"CF Howard Jr","year":"1986","unstructured":"Howard CF Jr (1986) Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29:301\u2013306","journal-title":"Diabetologia"},{"key":"1321_CR20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2337\/diabetes.49.8.1325","volume":"49","author":"SA Kassem","year":"2000","unstructured":"Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B (2000) \u00df-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325\u20131333","journal-title":"Diabetes"},{"key":"1321_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-979040","volume":"29","author":"RL Sorenson","year":"1997","unstructured":"Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301\u2013307","journal-title":"Horm Metab Res"},{"key":"1321_CR22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.1978.tb15835.x","volume":"85","author":"FA Assche Van","year":"1978","unstructured":"Van Assche FA, Aerts L, De Prins F (1978) A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 85:818\u2013820","journal-title":"Br J Obstet Gynaecol"},{"key":"1321_CR23","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2337\/diabetes.54.9.2557","volume":"54","author":"M Teta","year":"2005","unstructured":"Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA (2005) Very slow turnover of beta-cells in aged adult mice. Diabetes 54:2557\u20132567","journal-title":"Diabetes"},{"key":"1321_CR24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2337\/diab.42.12.1715","volume":"42","author":"S Bonner-Weir","year":"1993","unstructured":"Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715\u20131220","journal-title":"Diabetes"},{"key":"1321_CR25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/db07-1294","volume":"57","author":"BA Menge","year":"2008","unstructured":"Menge BA, Tannapfel A, Belyaev O et al (2008) Partial pancreatectomy in adult humans does not provoke \u00df-cell regeneration. Diabetes 57:142\u2013149","journal-title":"Diabetes"},{"key":"1321_CR26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1172\/JCI104130","volume":"39","author":"RS Yalow","year":"1960","unstructured":"Yalow RS, Berson SA (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157\u20131175","journal-title":"J Clin Invest"},{"key":"1321_CR27","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2337\/diabetes.51.7.2170","volume":"51","author":"CC Jensen","year":"2002","unstructured":"Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, American Diabetes Association GENNID Study Group (2002) \u00df-cell function is the major determinant of oral glucose tolerance in four ethnic groups in the United States. Diabetes 51:2170\u20132178","journal-title":"Diabetes"},{"key":"1321_CR28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199201023260104","volume":"326","author":"A Mitrakou","year":"1992","unstructured":"Mitrakou A, Kelley D, Mokan M et al (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22\u201329","journal-title":"N Engl J Med"},{"key":"1321_CR29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-9343(81)90579-9","volume":"70","author":"MA Pfeifer","year":"1981","unstructured":"Pfeifer MA, Halter JB, Porte D Jr (1981) Insulin secretion in diabetes mellitus. Am J Med 70:579\u2013588","journal-title":"Am J Med"},{"key":"1321_CR30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-42-2-222","volume":"42","author":"JD Brunzell","year":"1976","unstructured":"Brunzell JD, Robertson RP, Lerner RL et al (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222\u2013229","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00125-004-1454-z","volume":"47","author":"IF Godsland","year":"2004","unstructured":"Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157\u20131166","journal-title":"Diabetologia"},{"key":"1321_CR32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI111542","volume":"74","author":"WK Ward","year":"1984","unstructured":"Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318\u20131328","journal-title":"J Clin Invest"},{"key":"1321_CR33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2337\/diabetes.53.3.624","volume":"53","author":"S Deng","year":"2004","unstructured":"Deng S, Vatamaniuk M, Huang X et al (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624\u2013632","journal-title":"Diabetes"},{"key":"1321_CR34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/diabetes.54.3.727","volume":"54","author":"S Del Guerra","year":"2005","unstructured":"Del Guerra S, Lupi R, Marselli L et al (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54:727\u2013735","journal-title":"Diabetes"},{"key":"1321_CR35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2337\/diabetes.55.02.06.db04-1575","volume":"55","author":"CG Ostenson","year":"2006","unstructured":"Ostenson CG, Gaisano H, Sheu L, Tibell A, Bartfai T (2006) Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 55:435\u2013440","journal-title":"Diabetes"},{"key":"1321_CR36","first-page":"E479","volume":"257","author":"RW Bergstrom","year":"1989","unstructured":"Bergstrom RW, Fujimoto WY, Teller DC, De Haen C (1989) Oscillatory insulin secretion in perifused isolated rat islets. Am J Physiol 257:E479\u2013E485","journal-title":"Am J Physiol"},{"key":"1321_CR37","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198805123181902","volume":"318","author":"S O\u2019Rahilly","year":"1988","unstructured":"O\u2019Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225\u20131230","journal-title":"N Engl J Med"},{"key":"1321_CR38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1172\/JCI116560","volume":"92","author":"NM O\u2019Meara","year":"1993","unstructured":"O\u2019Meara NM, Sturis J, Van Cauter E, Polonsky KS (1993) Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 92:262\u2013271","journal-title":"J Clin Invest"},{"key":"1321_CR39","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/diab.46.11.1725","volume":"46","author":"SE Kahn","year":"1997","unstructured":"Kahn SE, Halban PA (1997) Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725\u20131732","journal-title":"Diabetes"},{"key":"1321_CR40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diab.44.2.173","volume":"44","author":"SE Kahn","year":"1995","unstructured":"Kahn SE, Leonetti DL, Prigeon RL, Bergstrom RW, Fujimoto WY (1995) Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173\u2013179","journal-title":"Diabetes"},{"key":"1321_CR41","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/BF00422366","volume":"38","author":"L Mykkanen","year":"1995","unstructured":"Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M (1995) Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38:1176\u20131182","journal-title":"Diabetologia"},{"key":"1321_CR42","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/diab.32.10.943","volume":"32","author":"WK Ward","year":"1983","unstructured":"Ward WK, Halter JB, Best JD, Beard JC, Porte D Jr (1983) Hyperglycemia and \u00df-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man. Diabetes 32:943\u2013947","journal-title":"Diabetes"},{"key":"1321_CR43","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1152\/ajpendo.00188.2004","volume":"288","author":"B Raju","year":"2005","unstructured":"Raju B, Cryer PE (2005) Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide. Am J Physiol Endocrinol Metab 288:E80\u2013E85","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1321_CR44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-54-1-131","volume":"54","author":"RA Rizza","year":"1982","unstructured":"Rizza RA, Mandarino LJ, Gerich JE (1982) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 54:131\u2013138","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF00296991","volume":"30","author":"WK Ward","year":"1987","unstructured":"Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr (1987) Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and experimental insulin resistance. Diabetologia 30:698\u2013702","journal-title":"Diabetologia"},{"key":"1321_CR46","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1210\/jcem-41-3-600","volume":"41","author":"SC Kalhan","year":"1975","unstructured":"Kalhan SC, Adam PAJ (1975) Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. J Clin Endocrinol Metab 41:600\u2013610","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJM197301182880305","volume":"288","author":"J Marco","year":"1973","unstructured":"Marco J, Calle C, Roman D, Diaz-Fierros M, Villaneuva ML (1973) Hyperglucagonism induced by glucocorticoid treatment in man. N Engl J Med 288:128\u2013131","journal-title":"N Engl J Med"},{"key":"1321_CR48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/0002-9343(78)90454-0","volume":"64","author":"P Raskin","year":"1978","unstructured":"Raskin P, Aydin I, Yamamoto T, Unger RH (1978) Abnormal alpha cell function in human diabetes: the response to oral protein. Am J Med 64:988\u2013997","journal-title":"Am J Med"},{"key":"1321_CR49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1172\/JCI108338","volume":"57","author":"RP Robertson","year":"1976","unstructured":"Robertson RP, Halter JB, Porte D Jr (1976) A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest 57:791\u2013795","journal-title":"J Clin Invest"},{"key":"1321_CR50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1172\/JCI113470","volume":"81","author":"JL Leahy","year":"1988","unstructured":"Leahy JL, Bonner-Weir S, Weir GC (1988) Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407\u20131414","journal-title":"J Clin Invest"},{"key":"1321_CR51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00125-002-1011-6","volume":"46","author":"MO Larsen","year":"2003","unstructured":"Larsen MO, Gotfredsen CF, Wilken M, Carr RD, Porksen N, Rolin B (2003) Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in G\u00f6ttingen minipigs. Diabetologia 46:195\u2013202","journal-title":"Diabetologia"},{"issue":"Suppl","key":"1321_CR52","first-page":"9","volume":"15","author":"N Porksen","year":"2002","unstructured":"Porksen N (2002) Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes. Diabetes Nutr Metab 15(Suppl):9\u201314","journal-title":"Diabetes Nutr Metab"},{"key":"1321_CR53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.33.7.667","volume":"33","author":"JL Leahy","year":"1984","unstructured":"Leahy JL, Bonner-Weir S, Weir GC (1984) Abnormal glucose regulation of insulin secretion in models of reduced B cell mass. Diabetes 33:667\u2013673","journal-title":"Diabetes"},{"key":"1321_CR54","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2337\/db08-0878","volume":"57","author":"A Ackermann Misfeldt","year":"2008","unstructured":"Ackermann Misfeldt A, Costa RH, Gannon M (2008) Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes 57:3069\u20133077","journal-title":"Diabetes"},{"key":"1321_CR55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diabetes.47.7.1046","volume":"47","author":"RA Pederson","year":"1998","unstructured":"Pederson RA, Satkunarajah M, McIntosh CH et al (1998) Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor \u2013\/\u2013 mice. Diabetes 47:1046\u20131052","journal-title":"Diabetes"},{"key":"1321_CR56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2337\/diabetes.52.2.365","volume":"52","author":"DD Leon De","year":"2003","unstructured":"De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA (2003) Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365\u2013371","journal-title":"Diabetes"},{"key":"1321_CR57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/er.2007-0023","volume":"29","author":"V Poitout","year":"2008","unstructured":"Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and \u00df-cell dysfunction. Endocr Rev 29:351\u2013366","journal-title":"Endocr Rev"},{"key":"1321_CR58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/diab.38.1.49","volume":"38","author":"S Bonner-Weir","year":"1989","unstructured":"Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic \u00df-cells in adult rats after short-term glucose infusion. Diabetes 38:49\u201353","journal-title":"Diabetes"},{"key":"1321_CR59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2337\/diabetes.47.4.640","volume":"47","author":"SE Kahn","year":"1998","unstructured":"Kahn SE, Verchere CB, Andrikopoulos S et al (1998) Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes 47:640\u2013645","journal-title":"Diabetes"},{"key":"1321_CR60","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","volume":"89","author":"RL Hull","year":"2004","unstructured":"Hull RL, Westermark GT, Westermark P, Kahn SE (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89:3629\u20133643","journal-title":"J Clin Endocrinol Metab"},{"key":"1321_CR61","first-page":"1333","volume":"38","author":"D Porte Jr","year":"1989","unstructured":"Porte D Jr, Kahn SE (1989) Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet \u00df-cell dysfunction? Diabetes 38:1333\u20131336","journal-title":"Diabetes"},{"key":"1321_CR62","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","volume":"55","author":"L Marzban","year":"2006","unstructured":"Marzban L, Rhodes CJ, Steiner DF, Haataja L, Halban PA, Verchere CB (2006) Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55:2192\u20132201","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1321-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-009-1321-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1321-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:47:10Z","timestamp":1558612030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-009-1321-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,27]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s00125-009-1321-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,27]]}}}